Haneen Nur

Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model

E. Bertrand, X. Leleu, R. Schots, 2013, PloS one.

The Role of Invariant Natural Killer T Cells in Cancer

K. Vanderkerken, E. Menu, E. D. Bruyne, 2013 .

Stimulation of invariant natural killer T cells by α‐Galactosylceramide activates the JAK‐STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model

D. Ribatti, A. Vacca, M. Frassanito, 2014, British journal of haematology.

Corynebacterium glutamicum survives arsenic stress with arsenate reductases coupled to two distinct redox mechanisms

L. M. Mateos, J. Collet, J. Messens, 2011, Molecular microbiology.

Preclinical Evaluation of Invariant Natural Killer T-Cells in the 5T33 Multiple Myeloma Model

D. Elewaut, S. Aspeslagh, K. Vanderkerken, 2012 .